Quest Diagnostics (DGX) PT Raised to $226 at Morgan Stanley
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $236.04 -0.73%
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Morgan Stanley analyst Erin Wright raised the price target on Quest Diagnostics (NYSE: DGX) to $226.00 (from $207.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Quest Diagnostics (DGX) Declares $0.86 Quarterly Dividend; 1.4% Yield
- Greens (6547:JP) PT Raised to JPY3,800 at Nomura/Instinet
- Quanta Computer Inc. (2382:TT) (QUCPF) PT Raised to NT$626 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
